Aurobindo Pharma has reported results for second quarter ended September 30, 2019.
The company has reported a marginal rise of 4.51% in its net profit at Rs 398.13 crore for the quarter under review as compared to Rs 380.95 crore for the same quarter in the previous year. Total income of the company marginally increased by 2.54% at Rs 3,255.30 crore for Q2FY20 as compared Rs 3174.57 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a marginal rise of 4.59% in its net profit at Rs 639.53 crore for the quarter under review as compared to Rs 611.44 crore for the same quarter in the previous year. Total income of the company increased by 17.65% at Rs 5,621.09 crore for Q2FY20 as compared Rs 4,777.66 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1464.85 |
Dr. Reddys Lab | 5955.65 |
Cipla | 1477.15 |
Zydus Lifesciences | 1050.35 |
Lupin | 1603.55 |
View more.. |